{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:10:18Z","timestamp":1758633018733},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/beha.2002.0227","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T18:13:53Z","timestamp":1046801633000},"page":"675-693","source":"Crossref","is-referenced-by-count":5,"title":["Autologous stem cell transplantation and purging in adult acute lymphoblastic leukaemia"],"prefix":"10.1053","volume":"15","author":[{"given":"Albert","family":"Gra\u00f1ena Batista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Ferra Coll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2002.0227_RF1","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood.V73.8.2051.2051","article-title":"Acute lymphoblastic leukemia: recent advances in biology and therapy","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF2","first-page":"27","article-title":"Acute lymphoblastic leukemia in adults: recent progress, future directions","volume":"24","author":"Hoelzer","year":"1987","journal-title":"Seminars in Hematology"},{"key":"10.1053\/beha.2002.0227_RF3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM198607313150501","article-title":"Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study","volume":"315","author":"Rivera","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0227_RF4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.1988.6.6.1014","article-title":"A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital Experience since 1969","volume":"6","author":"Gaynor","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0227_RF5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(87)90128-0","article-title":"Which treatment for childhood acute lymphoblastic leukaemia in second remission?","volume":"i","author":"Butturini","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0227_RF6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1182\/blood.V71.1.123.123","article-title":"Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukaemia in adults","volume":"71","author":"Hoelzer","year":"1988","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF7","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1200\/JCO.1996.14.9.2480","article-title":"Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia with out the use of vincristine or prednisone","volume":"14","author":"Weiss","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0227_RF8","first-page":"78","article-title":"Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia","volume":"14","author":"Linker","year":"1987","journal-title":"Seminars in Oncology"},{"key":"10.1053\/beha.2002.0227_RF9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V62.3.606.606","article-title":"Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults","volume":"62","author":"Stryckmans","year":"1983","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10428199509075308","article-title":"Techniques for detection of minimal residual disease","volume":"18","author":"Carlo-Stella","year":"1995","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0227_RF11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"339","author":"Cav\u00e9","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0227_RF12","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.1993.11.10.1990","article-title":"Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as post-remission therapy","volume":"11","author":"Fi\u00e8re","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0227_RF13","first-page":"7","article-title":"Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission","volume":"5","author":"Blaise","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF14","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.1990.8.6.994","article-title":"Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard-and high-risk acute lymphocytic leukemia","volume":"8","author":"Kantarjian","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0227_RF15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood.V77.7.1593.1593","article-title":"Autologous bone marrow transplantation for high-risk-grade lymphoid malignancy using melphalan-irradiation conditioning without marrow purging or cryopreservation","volume":"77","author":"Carey","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF16","first-page":"241","article-title":"Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission. 50 cases of a single center","volume":"16","author":"Powles","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF17","first-page":"383","article-title":"Bone marrow transplantation in 63 adult patints with acute lymphoblastic leukemia in first complete remission","volume":"14","author":"Vey","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF18","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V86.4.1619.bloodjournal8641619","article-title":"Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation","volume":"86","author":"Attal","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/10428199309067935","article-title":"Long-term results of autologous bone marrow transplantation in adult acute lymphoblastic leukemia","volume":"11","author":"Laambertenghi Deliliers","year":"1993","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0227_RF20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.1987.5.9.1348","article-title":"Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease","volume":"5","author":"Weisdorf","year":"1987","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0227_RF21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/1097-0142(19920201)69:3<709::AID-CNCR2820690318>3.0.CO;2-G","article-title":"Treatment of relapsed or refractory adult acute lymphocytic leukemia","volume":"69","author":"Freund","year":"1992","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0227_RF22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198708203170801","article-title":"Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia","volume":"317","author":"Kersey","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0227_RF23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.1988.tb07599.x","article-title":"A comparative study of combination chemotherapy versus marrow transplant in first remission in acute lymphoblastic leukemia","volume":"69","author":"Proctor","year":"1988","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0227_RF24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10428199809068567","article-title":"Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Helg","year":"1998","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0227_RF25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.1990.8.5.820","article-title":"Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia","volume":"8","author":"Wingard","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0227_RF26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood.V74.2.862.862","article-title":"Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival","volume":"74","author":"Barret","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.bmt.1701221","article-title":"Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia","volume":"21","author":"Martino","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF28","first-page":"116","article-title":"Allogeneic or autologous bone marrow transplantation for intensification of salvage therapy in patients with high-risk advanced acute lymphoblastic leukemia","volume":"3","author":"Arcese","year":"1991","journal-title":"Seminars in Hematology"},{"key":"10.1053\/beha.2002.0227_RF29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1365-2141.1997.1102926.x","article-title":"Tretament of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol","volume":"97","author":"Giona","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0227_RF30","first-page":"243","article-title":"Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse","volume":"12","author":"Soiffer","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF31","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood.V99.9.3151","article-title":"Unrelated marrow transplantation for children with acute leukemia in second remission","volume":"99","author":"Bunin","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF32","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V90.8.2962","article-title":"Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia","volume":"90","author":"Weisdorf","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one full mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0227_RF34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199708073370602","article-title":"Outcome of cord-blood transplantation from related and unrelated donors","volume":"337","author":"Gluckman","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0227_RF35","first-page":"255","article-title":"Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex marrow leukemia cell purging with monoclonal antibodies and complement","volume":"11","author":"Morishima","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/beha.2002.0227_RF36","series-title":"Autologous Blood and Marrow Transplantation. Proceedings of the Ninth International Symposium (Arlington, Texas)","first-page":"72","article-title":"Autologous hematopoietic stem cell transplantation as treatment for adult acute lymphoblastic leukemia","author":"Sierra","year":"1999"},{"key":"10.1053\/beha.2002.0227_RF37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/scd.1.1997.6.261","article-title":"Immunomagnetic bone marrow purging in children with acute lymphoblastic leukemia","volume":"6","author":"Canals","year":"1997","journal-title":"Journal of Hematotherapy"},{"key":"10.1053\/beha.2002.0227_RF38","first-page":"315","article-title":"Autologous bone marrow transplantation for acute lymphoblastic leukaemia","volume":"12","author":"Doney","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF39","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1200\/JCO.1989.7.11.1594","article-title":"Autologous bone marrow transplantation for acute lymphoblastic leukemia","volume":"7","author":"Sallan","year":"1989","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0227_RF40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V81.6.1651.1651","article-title":"Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia","volume":"81","author":"Billet","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF41","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.bmt.1701507","article-title":"Autologous bone marrow transplantation with monoclonal antibody purged marrow for children with acute lymphoblastic leukemia in second remission","volume":"22","author":"Maldonado","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1701957","article-title":"Autologous bone marrow transplantation for high.risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement","volume":"24","author":"Gra\u00f1ena","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF43","first-page":"821","article-title":"Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: first choice of isolated extramedullary relapse?","volume":"14","author":"Colleselli","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bmt.1701052","article-title":"Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia","volume":"21","author":"Messina","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF45","first-page":"9","article-title":"Bone marrow transplantation for acute lymphoblastic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing regimens","volume":"6","author":"Woods","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/beha.2002.0227_RF46","first-page":"645","article-title":"Total body irradiation and high dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia","volume":"71","author":"Krance","year":"1987","journal-title":"Cancer Treatment Reports"},{"key":"10.1053\/beha.2002.0227_RF47","first-page":"167","article-title":"Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclines","volume":"4","author":"Raemaekers","year":"1989","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF48","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM198712243172602","article-title":"Allogeneic bone marrow transplantation after hyperfractionated total body irradiation and cyclophosphamide in children with acute leukemia","volume":"317","author":"Brochstein","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0227_RF49","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2141.1995.tb08416.x","article-title":"High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: a 7-year Italian multicentre study","volume":"89","author":"Underzo","year":"1995","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0227_RF50","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V80.6.1423.1423","article-title":"Autologous bone marrow purging in acute leukemia with marrow purged with Alkyl-Lysophospholipid","volume":"80","author":"Vogler","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF51","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplant during first remission of acute myeloid leukemia","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V81.2.319.319","article-title":"Busulfan\/etoposide \u2013 initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute non-lymphoblastic leukemia","volume":"81","author":"Chao","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10428199709039035","article-title":"Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: long-term follow-up","volume":"25","author":"Metha","year":"1997","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0227_RF54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bmt.1702857","article-title":"Monoclonal antibodies and autologous stem cell transplantation for lymphoma","volume":"27","author":"Flinn","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF55","first-page":"319","article-title":"Factors affecting engraftment and hematopoietic recovery after unpurged autographing in acute leukemia","volume":"18","author":"Metha","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bmt.1702750","article-title":"Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno and chemotherapy (PTIC)","volume":"27","author":"Houtenbos","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bmt.1701576","article-title":"Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study","volume":"23","author":"Lemoli","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/10428199309145754","article-title":"Mobilization of cytogenetically \u2018normal\u2019 progenitors cell by intensive chemotherapy for chronic myeloid and acute lymphoblastic leukemia","volume":"9","author":"Carella","year":"1993","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0227_RF59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2141.1996.7292351.x","article-title":"In vivo mobilization of kariotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia","volume":"95","author":"Carella","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0227_RF60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.bmt.1702096","article-title":"Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia vs peripheral blood stem cells by semiquantitative polymerase chain reaction","volume":"25","author":"Atta","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF61","first-page":"329","article-title":"Quantification of residual disease in Philadelphia positive acute lymphoblastic leukemia: comparison of blood and bone marrow","volume":"9","author":"van Rhee","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0227_RF62","first-page":"1269","article-title":"Identical-twin (Syngeneic) marrow transplantation for hematologic cancers","volume":"76","author":"Fefer","year":"1986","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1053\/beha.2002.0227_RF63","first-page":"1612","article-title":"Purging of peripheral blood stem cells yields BCR-ABL-negative autographs in patients with BCR-ABL-positive acute lymphoblastic leukemia","volume":"23","author":"Martin","year":"1995","journal-title":"Experimental Hematology"},{"key":"10.1053\/beha.2002.0227_RF64","first-page":"541","article-title":"Residual leukemia and immunomagnetic bead purging in patients with BCR-ABL-positive acute lymphoblastic leukemia","volume":"18","author":"Atta","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF65","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood.V83.10.3068.3068","article-title":"Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML","volume":"83","author":"Deisseroth","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","article-title":"Gene-marking to trace origin of relapse after autologous bone-marrow transplantation","volume":"341","author":"Brenner","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0227_RF67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/scd.1.1994.3.203","article-title":"Bone marrow purging in acute lymphoblastic leukemia: biological and clinical features","volume":"3","author":"Garcia","year":"1994","journal-title":"Journal of Hematotherapy"},{"key":"10.1053\/beha.2002.0227_RF68","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V76.9.1723.1723","article-title":"Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxin plus 4-hydroperoxycyclophosphamide for marrow purging","volume":"9","author":"Uckun","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF69","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.V79.4.1094.bloodjournal7941094","article-title":"Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1\/CD24, BA-2\/CD9 and BA-3\/CD10) plus complement and 4-hydroperoxycyclophosphamide forex vivo bone marrow purging","volume":"4","author":"Uckun","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF70","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1182\/blood.V86.7.2849.2849","article-title":"Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging","volume":"86","author":"Douay","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF71","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.V74.3.1159.1159","article-title":"Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in remission or early relapse","volume":"74","author":"Rosenfeld","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood.V70.1.271.271","article-title":"GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow","volume":"70","author":"Rowley","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF73","first-page":"19","article-title":"Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukemia in first complete remision","volume":"8","author":"Gilmore","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF74","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1182\/blood.V84.11.3810.bloodjournal84113810","volume":"84","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF75","first-page":"1008","article-title":"In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors","volume":"18","author":"Lemoli","year":"1990","journal-title":"Experimental Hematology"},{"key":"10.1053\/beha.2002.0227_RF76","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0145-2126(01)00164-3","article-title":"Purging in autologous hematopoietic stem cell transplantation using adenosine triphosphate (ATP) and 4-hydroperoxycyclophosphamide","volume":"26","author":"Hatta","year":"2002","journal-title":"Leukemia Research"},{"key":"10.1053\/beha.2002.0227_RF77","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V65.6.1504.bloodjournal6561504","article-title":"Autologous bone marrow transplantation in acute leukemia: A phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells","volume":"65","author":"Kaiser","year":"1985","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00043426-199023000-00001","article-title":"Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations","volume":"12","author":"Yeager","year":"1990","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"key":"10.1053\/beha.2002.0227_RF79","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mpo.2950190303","article-title":"Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia","volume":"19","author":"Gonzales-Chambers","year":"1991","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0227_RF80","first-page":"569","article-title":"The effect of alkyl-lysophospholipids on tritiated thymidineincorporation and clonogenicity in vitro of normal and leukemic human cells","volume":"12","author":"Vogler","year":"1984","journal-title":"Experimental Hematology"},{"key":"10.1053\/beha.2002.0227_RF81","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0959-8049(98)00412-2","article-title":"Amifostine (WR 2721) for dose escalation in marrow-ablative treatment of leukemia","volume":"35","author":"Martens","year":"1999","journal-title":"European Journal of Cancer"},{"key":"10.1053\/beha.2002.0227_RF82","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1182\/blood.V83.11.3132.3132","article-title":"Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support","volume":"83","author":"Shpall","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF83","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood.V62.2.327.327","article-title":"Use of an antibody-ricin A chain conjugate to delete neoplastic B cells from human bone marrow","volume":"62","author":"Muirhead","year":"1983","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2141.1987.tb06161.x","article-title":"Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins","volume":"67","author":"Katz","year":"1987","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0227_RF85","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood.V74.3.1152.1152","article-title":"Autologous transplantation of bone marrow purged in vitro with anti-CD-7 (WTI-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma","volume":"74","author":"Preijers","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF86","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/blood.V69.2.597.597","article-title":"Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow","volume":"69","author":"Anderson","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF87","first-page":"631","article-title":"Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia","volume":"9","author":"Simonsson","year":"1989","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0227_RF88","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood.V66.3.508.508","article-title":"Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remision: resuls of bone marrow treated with monoclonal antibodies BA-1, BA-2 and BA-3 plus complement","volume":"66","author":"Ramsay","year":"1985","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF89","first-page":"597","article-title":"Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia","volume":"12","author":"Schmid","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF90","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/scd.1.1997.6.495","article-title":"Optimization of purging of autologous bone marrow grafts for children with precursor B acute lymphoblastic leukemia","volume":"6","author":"Vervoordeldonk","year":"1997","journal-title":"Journal of Hematotherapy"},{"key":"10.1053\/beha.2002.0227_RF91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02893581","article-title":"An effective, direct immunomagnetic procedure for purging acute lymphoblastic leukemia cells from human bone marrow","volume":"1","author":"Wang","year":"1995","journal-title":"Pathology Oncology Research"},{"key":"10.1053\/beha.2002.0227_RF92","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V80.4.1083.1083","article-title":"Bone marrows of non-Hodgkin's lymphoma patients with bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion","volume":"80","author":"Gribben","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF93","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(82)91686-5","article-title":"Autologous bone marrow transplantation in CALLA positive acute lymphoblastic leukemia after in vitro treatment with J5 monoclonal antibody and complement","volume":"2","author":"Ritz","year":"1982","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0227_RF94","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood.V97.12.3925","article-title":"Detection of leukemic cells in the CD34(+)CD38(\u2212) bone marrow progenitor population in children with acute lymphoblastic leukemia","volume":"98","author":"George","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0145-2126(86)90036-6","article-title":"Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamide (ASTA Z 7557)","volume":"10","author":"LeBien","year":"1986","journal-title":"Leukemia Research"},{"key":"10.1053\/beha.2002.0227_RF96","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.134.5.3504","article-title":"Combined ex vivo treatment with immunotoxins and mafosfamide: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts","volume":"134","author":"Uckun","year":"1985","journal-title":"Journal of Immunology"},{"key":"10.1053\/beha.2002.0227_RF97","first-page":"193","article-title":"A novel approach to purging of leukemia by activation of bone marrow with interleukin-2","volume":"6","author":"Charak","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF98","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/scd.1.1997.6.457","article-title":"A pilot study evaluating interleukin-2-activated hematopoietic stem cell transplantation for hematologic malignancies","volume":"6","author":"Meehan","year":"1997","journal-title":"Journal of Hematotherapy"},{"key":"10.1053\/beha.2002.0227_RF99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/15258160151135006","article-title":"Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapy","volume":"10","author":"Meehan","year":"2001","journal-title":"Journal of Hematotherapy Stem Cell Research"},{"key":"10.1053\/beha.2002.0227_RF100","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V99.4.1150","article-title":"Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study","volume":"99","author":"Lunger","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF101","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1182\/blood.V91.9.3156","article-title":"BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase","volume":"91","author":"De Fabritiis","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF102","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.bmt.1701190","article-title":"Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood","volume":"21","author":"Gruhn","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF103","first-page":"625","article-title":"Phase I study of alpha-inerferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation","volume":"13","author":"Tatanatharathorn","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF104","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.6367046","article-title":"Biological activity of recombinant interleukin-2 produced in E. coli","volume":"223","author":"Rosenberg","year":"1984","journal-title":"Science"},{"key":"10.1053\/beha.2002.0227_RF105","first-page":"724","article-title":"In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and survival","volume":"8","author":"Lauria","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0227_RF106","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1182\/blood.V77.12.2561.2561","article-title":"Toxicity and immunomodulatory effects of interleukin-2 after autologous bone marrow transplantation for hematologic malignancies","volume":"77","author":"Higuchi","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF107","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V76.6.1092.1092","article-title":"Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation","volume":"76","author":"Blaise","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0227_RF108","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bmt.1700687","article-title":"Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I\/II study","volume":"19","author":"Robinson","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0227_RF109","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/10428199509054425","article-title":"Is there a place for immunotherapy with interleukin-2 to prevent relapse after autologous stem cell transplantation for acute leukemia?","volume":"16","author":"Klingemann","year":"1995","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0227_RF110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007890-199301000-00012","article-title":"Interleukin-2 immediately after autologous bone marrow transplantation for acute lymphoblastic leukemia. A phase I study","volume":"55","author":"Weisdorf","year":"1993","journal-title":"Transplantation"},{"key":"10.1053\/beha.2002.0227_RF111","first-page":"780","article-title":"Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study","volume":"6","author":"Meloni","year":"1992","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0227_RF112","unstructured":"Tiley, C, Powles, R, Treleaven, J, Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukemia, Bone Marrow Transplantation, 1993, 12, 449, 455"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T21:37:58Z","timestamp":1682458678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692602902276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S1521692602902276"],"URL":"https:\/\/doi.org\/10.1053\/beha.2002.0227","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}